Management Team


Charles W. Bishop, PhD Chief Executive Officer
Douglass Laidlaw, PhD Vice President, Medical Affairs
Martin Petkovich, PhD Chief Scientific Officer

Douglass Laidlaw, PhD - Vice President, Medical Affairs

Dr. Laidlaw joined OPKO Health with 15 years of biopharmaceutical industry experience in Medical Affairs, most recently as President of Summit Scientific Consulting, providing Medical Affairs and Clinical Development consulting services to the pharmaceutical industry.  Previously, Dr. Laidlaw was Executive Director of Medical Affairs at Relypsa, where he developed the Medical Affairs strategic plan and was responsible for deploying the nephrology and cardiology field Medical Affairs team for a launch year.  During several years prior to joining Relypsa, Dr. Laidlaw held positions of increasing responsibility in Renal Medical Affairs with Sanofi/Genzyme.  As the National Director, Medical Science Liaisons, he and his team provided medical support for Renagel®(sevelamer hydrochloride), Renvela®(sevelamer carbonate) and oral and injectable Hectorol®(doxercalciferol).  Dr. Laidlaw has also held Medical Affairs positions with several other established biopharmaceutical companies such as Keryx Biopharmaceuticals, Neurocrine Biosciences, Serono and Organon Pharmaceuticals.  Dr. Laidlaw received his Ph.D. in Physiological Sciences from the University of Arizona.

 
     
     
 
   

© 2017 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use